Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC VUF11207 fumarate | 1785665-61-3 | 99.9% | 586.65 g/mol | C31H39FN2O8 | 5 MG
Supplier: Medchemexpress LLC HY1103185MG
VUF11207 fumarate is a research-grade small-molecule agonist of the chemokine receptor CXCR7 (ACKR3). It selectively binds CXCR7 and has been reported to reduce CXCL12-mediated osteoclastogenesis and bone resorption through inhibition of ERK phosphorylation. The compound is supplied for laboratory research use only.
- Selective CXCR7 agonist with reported activity in CXCL12 signaling.
- Reduces CXCL12-mediated osteoclastogenesis and bone resorption by inhibiting ERK phosphorylation.
- High purity suitable for in vitro studies (99.94%).
- Available as solid and as a 10 mM solution in DMSO; multiple solid package sizes available.
- Intended for research use only; not for human or veterinary use.
- Applicable to receptor pharmacology and cell-based signaling assays.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?